Burton E. Sobel
Keine laufenden Positionen mehr
Profil
Burton E.
Sobel served as a Director for various pharmaceutical companies including Clinical Data, Inc., ARIAD Pharmaceuticals, Inc., Nuvelo, Inc., and New River Pharmaceuticals, Inc. He also served as an Executive Director for Third Security LLC and as an Independent Director for ARCA biopharma, Inc. In addition, he was a Professor at the University of Washington and the University of Vermont, and a Trustee for The University of Vermont Medical Center.
Sobel holds a doctorate from Harvard University and an undergraduate degree from Cornell University.
Ehemalige bekannte Positionen von Burton E. Sobel
| Unternehmen | Position | Ende |
|---|---|---|
| ARCA BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 02.05.2013 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Direktor/Vorstandsmitglied | 01.04.2007 |
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Direktor/Vorstandsmitglied | 12.04.2011 |
| Nuvelo, Inc. | Direktor/Vorstandsmitglied | 28.01.2009 |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Direktor/Vorstandsmitglied | 27.01.2009 |
Ausbildung von Burton E. Sobel
| Cornell University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| ARCA BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Third Security LLC
 Third Security LLC Investment ManagersFinance Third Security LLC (Third Security) is a private equity firm founded in 1999 by Randal J. Kirk. The firm is headquartered in Radford, Virginia. | Finance |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
| Nuvelo, Inc. | Health Technology |
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Health Technology |
| Society for Experimental Biology & Medicine | |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
The University of Vermont Medical Center
 The University of Vermont Medical Center Medical/Nursing ServicesHealth Services The University of Vermont Medical Center provides healthcare services. The firm's services include the Level 1 Trauma Center, the Vermont Children's Hospital, the Vermont Cancer Center, the Ambulatory Care Center, and the Birthing Center. The company was founded in 1995 and is headquartered in Burlington, VT. | Health Services |
